肝移植术后耐激素性急性排斥反应的诊疗现状

Current status of diagnosis and treatment of steroid resistant acute rejection after liver transplantation

  • 摘要: 实体器官移植术后急性排斥反应的发生后常采用大剂量糖皮质激素(激素)冲击治疗,但大剂量激素冲击治疗对部分患者无效,即耐激素性急性排斥反应,易导致移植物丢失,严重影响患者预后。目前认为细胞介导的排斥反应和抗体介导的排斥反应均参与了耐激素性急性排斥反应的发生发展。肾移植术后耐激素性急性排斥反应的诊断与治疗已比较成熟,而肝移植术后耐激素性急性排斥反应国内以往关注较少,目前尚未形成统一规范的治疗方案。因此,本文就肝移植术后耐激素性急性排斥反应的发病机制、诊断及治疗进行综述,以期为肝移植术后耐激素性急性排斥反应的诊疗提供参考。

     

    Abstract: After solid organ transplantation, acute rejection often occur, and high-dose glucocorticoid (steroid) pulse therapy is commonly used to treat them. However, high-dose steroid pulse therapy is ineffective for some patients, leading to steroid-resistant acute rejection, which may easily result in graft loss and severely affect patient prognosis. It is currently believed that both cell-mediated rejection and antibody-mediated rejection are involved in the occurrence and development of steroid resistant acute rejection. The diagnosis and treatment of steroid resistant acute rejection after kidney transplantation have become relatively mature, while the focus on steroid resistant acute rejection after liver transplantation has been relatively low in the past in China, and a unified standardized treatment plan has not yet been formed. Therefore, this article reviews the pathogenesis, diagnosis, and treatment of steroid resistant acute rejection after liver transplantation, in order to provide a reference for the diagnosis and treatment of steroid resistant acute rejection after liver transplantation.

     

/

返回文章
返回